Hypertriglyceridemia Management — free guideline decision tool
This tool directs hypertriglyceridemia management by triglyceride level and ASCVD risk, distinguishing pancreatitis prevention in severe disease from cardiovascular risk reduction in mild-moderate disease.
Open guideline tool →Guideline-based
Implements the decision logic from published clinical guidelines.
Runs in your browser
No installation. Enter the patient's values and get a guideline recommendation instantly.
Data stays local
Nothing is uploaded. Results are for licensed clinicians only.
Common questions
What does Hypertriglyceridemia Management do?
Use to choose the main line: severe TG (≥ 500 mg/dL) prioritizes a fibrate and very-low-fat diet to prevent pancreatitis, while mild-moderate TG is lifestyle-led with a statin and possible icosapent ethyl.
How is the result calculated?
Severe (≥ 500 mg/dL) → fibrate + very-low-fat diet + treat secondary causes (± ω-3), statin only after TG < 500. Mild-moderate (150–499) → lifestyle + statin by risk; high-risk on statin with TG ≥ 150 → add icosapent ethyl.
Is this a substitute for clinical judgement?
No. All results are decision-support only, for licensed clinicians. They must be individualized to the whole patient and the latest guideline version.
Run Hypertriglyceridemia Management now
This tool directs hypertriglyceridemia management by triglyceride level and ASCVD risk, distinguishing pancreatitis prevention in severe disease from cardiovascular risk reduction in mild-moderate disease.
Open guideline tool →For licensed clinicians. Not a substitute for clinical judgement.